# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants

> **NCT03188783** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** GDC-0853
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03188783
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-24
- **Primary completion:** 2017-08-09
- **Final completion:** 2017-08-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188783, "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03188783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*